Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC

NCT05608369 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI left

Conditions

HPV-Related Squamous Cell Carcinoma
Squamous Cell Carcinoma of the Oral Cavity
Squamous Cell Carcinoma of the Larynx
Squamous Cell Carcinoma of the Oropharynx
Squamous Cell Carcinoma of the Hypopharynx

Interventions

DRUG: Cisplatin
RADIATION: Radiation therapy
DRUG: Vorinostat

Sponsor

Case Comprehensive Cancer Center